WeVote
Log In

Bill

Bill

SD 2084

An Act relative to PANDAS/PANS screening in medical/clinical settings

194th Legislature (2025-2026) Introduced by Patrick O'Connor

Requires Massachusetts healthcare providers to screen patients for PANDAS/PANS, a contested pediatric neuropsychiatric diagnosis linked to streptococcal infection or immune dysfunction.

House concurred
0
WeVote Research Nonpartisan
Bill Summary · SD 2084

Legislative bill overview

SD 2084 requires medical and clinical settings in Massachusetts to implement screening protocols for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). The bill mandates that healthcare providers assess patients presenting with acute neuropsychiatric symptoms for these conditions, establishing standardized screening procedures across the state's medical system.

Why is this important

PANDAS and PANS are controversial diagnoses where sudden-onset psychiatric symptoms (obsessive-compulsive disorder, tics, anxiety) are attributed to infection or immune dysfunction. Mandating screening could increase early identification and treatment for children experiencing these symptoms, but could also lead to overdiagnosis and unnecessary treatments if the underlying medical mechanisms remain scientifically contested. This directly affects how Massachusetts providers evaluate and treat children with acute behavioral changes.

Potential points of contention

  • Scientific consensus gap: PANDAS/PANS lack full acceptance by major medical organizations (AAP, AACAP) as distinct diagnostic entities, making mandatory screening potentially premature
  • Resource allocation: Screening requirements may burden healthcare systems and increase costs without clear evidence of improved outcomes
  • Overdiagnosis risk: Standardized screening protocols could lead to false positives and unnecessary antibiotic or immunological treatments in children
  • Liability concerns: Healthcare providers may face pressure to screen and treat conditions with uncertain evidence base, creating legal and ethical complications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.